CA1108053A - Medicament ophtalmique a liberation continue - Google Patents

Medicament ophtalmique a liberation continue

Info

Publication number
CA1108053A
CA1108053A CA318,447A CA318447A CA1108053A CA 1108053 A CA1108053 A CA 1108053A CA 318447 A CA318447 A CA 318447A CA 1108053 A CA1108053 A CA 1108053A
Authority
CA
Canada
Prior art keywords
gel
ophthalmic
accordance
polymer
ophthalmic drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA318,447A
Other languages
English (en)
Inventor
Ronald D. Schoenwald
Robert E. Roehrs
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Vision LLC
Original Assignee
Alcon Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Laboratories Inc filed Critical Alcon Laboratories Inc
Application granted granted Critical
Publication of CA1108053A publication Critical patent/CA1108053A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA318,447A 1978-01-25 1978-12-21 Medicament ophtalmique a liberation continue Expired CA1108053A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87207478A 1978-01-25 1978-01-25
US872,074 1978-01-25

Publications (1)

Publication Number Publication Date
CA1108053A true CA1108053A (fr) 1981-09-01

Family

ID=25358780

Family Applications (1)

Application Number Title Priority Date Filing Date
CA318,447A Expired CA1108053A (fr) 1978-01-25 1978-12-21 Medicament ophtalmique a liberation continue

Country Status (7)

Country Link
JP (2) JPS6059885B2 (fr)
CA (1) CA1108053A (fr)
CH (1) CH640737A5 (fr)
DE (1) DE2902863C2 (fr)
FR (1) FR2415459A1 (fr)
GB (1) GB2013084B (fr)
MX (1) MX6520E (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE6466T1 (de) 1979-10-26 1984-03-15 Smith And Nephew Associated Companies P.L.C. Autoklavierbare emulsionen.
GB2075837B (en) * 1980-05-14 1984-03-14 Hisamitsu Pharmaceutical Co Topical pharmaceutical gel containing anti-inflammatory analgesic agents
US6255299B1 (en) 1985-01-07 2001-07-03 Leo Pharmaceutical Products Ltd. Opthalmic gel composition and method of treating eye infections
GB8500310D0 (en) * 1985-01-07 1985-02-13 Leo Pharm Prod Ltd Pharmaceutical preparation
US5192535A (en) * 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
US5188826A (en) * 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
US5124154A (en) * 1990-06-12 1992-06-23 Insite Vision Incorporated Aminosteroids for ophthalmic use
JP2873530B2 (ja) * 1991-12-13 1999-03-24 参天製薬株式会社 ニュートン型粘性を示すカルボキシビニルポリマー含有点眼液基剤
CN1049358C (zh) * 1993-01-01 2000-02-16 参天制药株式会社 含羧酸乙烯聚合物的滴眼剂及其制造方法
US5340572A (en) * 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
DE69523044T2 (de) 1994-03-04 2002-06-20 Univ Washington Seattle Block- und pfropfcopolymere und dazu gehöriges verfahren
US5683709A (en) * 1994-05-05 1997-11-04 Ciba Vision Corporation Poly(benzalkonium salt) as an anti-microbial agent for aqueous drug compositions
DE19614823A1 (de) * 1996-04-15 1997-10-16 Mann Gerhard Chem Pharm Fab Ophthalmische Zusammensetzung mit verlängerter Verweilzeit am Auge
MXPA02003731A (es) 1999-10-15 2003-12-11 Leo Pharm Prod Ltd Derivados novedosos de acido fusidico.
DK1654002T4 (da) * 2003-08-07 2014-02-17 Allergan Inc Sammensætninger til fremføring af terapeutiske midler til øjnene
DE102010009475B4 (de) 2010-02-26 2011-11-24 F. Holzer Gmbh Verfahren zur Herstellung eines dosierbaren applikationsfertigen Präparates

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1012060A (en) * 1964-10-06 1977-06-14 Gilman N. Cyr Dimethyl sulfoxide gel preparations
FR2038105A1 (fr) * 1969-04-01 1971-01-08 Syntex Corp Composition anti-inflammatoire locale et son mode d'utilisation
DK135267A (fr) * 1971-02-25
DE2239206A1 (de) * 1971-08-12 1973-03-15 Hydrophilics Int Inc Copolymer
US3957740A (en) * 1972-04-24 1976-05-18 Hydrophilics International, Inc. Copolymers
FR2191941A1 (en) * 1972-07-10 1974-02-08 Serabonian Giacomo Gelatinising water-sol and aq liqs - by addn of carboxypolymer and alginic acid salt
DE2265164C3 (de) * 1972-10-18 1985-08-22 Vsesojuznyj naučno-issledovatel'skij i ispytatel'nyj institut medicinskoj techniki, Moskau/Moskva Verwendung von Acrylsäureamidcopolymeren zur Herstellung von Grundlagen für ophthalmologische Arzneiformen
AR206692A1 (es) * 1972-12-27 1976-08-13 Alza Corp Agente dispensador de liberacion sostenida de substancias activas
LU70487A1 (fr) * 1974-07-08 1976-05-31
US4003991A (en) * 1974-08-27 1977-01-18 National Patent Development Corporation Ophthalmic formulation
JPS5138412A (en) * 1974-09-24 1976-03-31 Nippon Kayaku Kk Kokoseizai no seiho
IL50250A (en) * 1975-08-27 1980-01-31 Hydrophilics Int Inc Sustained release compositions comprising slats of pharmaceutically acitve bases with polymers containing acid groups
JPS6056684B2 (ja) * 1977-11-07 1985-12-11 東興薬品工業株式会社 点眼剤

Also Published As

Publication number Publication date
FR2415459B1 (fr) 1983-03-18
GB2013084B (en) 1982-07-28
FR2415459A1 (fr) 1979-08-24
CH640737A5 (de) 1984-01-31
JPS6059885B2 (ja) 1985-12-27
DE2902863C2 (de) 1994-02-24
JPS54110312A (en) 1979-08-29
JPH0428244B2 (fr) 1992-05-13
JPS62215518A (ja) 1987-09-22
DE2902863A1 (de) 1979-07-26
MX6520E (es) 1985-06-27
GB2013084A (en) 1979-08-08

Similar Documents

Publication Publication Date Title
US4271143A (en) Sustained release ophthalmic drug dosage
US4407792A (en) Sustained release ophthalmic drug dosage
CA1108053A (fr) Medicament ophtalmique a liberation continue
US5275820A (en) Stable suspension formulations of bioerodible polymer matrix microparticles incorporating drug loaded ion exchange resin particles
US5441732A (en) Reversible gelation emulsion compositions and methods of use
US5461081A (en) Topical ophthalmic pharmaceutical vehicles
AU666091B2 (en) Compositions for controlled delivery of pharmaceutical compounds
US4115544A (en) Ocular system made of bioerodible esters having linear ether
CA2147362C (fr) Vehicules pharmaceutiques ophtalmiques pour applications topiques
WO1994010976A1 (fr) Systeme d'administration de medicaments ophtalmiques a base de borate/alcool polyvinylique
JP2536806B2 (ja) ゲル化多糖類と微粉砕された薬剤担体とを組み合わせた局部眼科用組成物
WO1984004681A1 (fr) Solution ophtalmique
WO1998011874A1 (fr) Composition pharmaceutique formant un gel
JPH08510731A (ja) 治療使用のためのその場で生成するゲル
US5827835A (en) Thermally-gelling emulsions
JP3269770B2 (ja) 再分散性の優れたイオン性高分子配合水性懸濁点眼剤
EP0711147A1 (fr) Suspensions servant a l'administration d'un medicament
EP0424042A1 (fr) Composition ophtalmique non-solide et procédé de préparation de ladite composition
Manasa et al. FORMULATION AND EVALUATION OF MOXIFLOXACIN OCULAR MICROEMULSION GEL

Legal Events

Date Code Title Description
MKEX Expiry